| Course | NUR 550 Evidence-Based Practice and Scholarly Inquiry |
|---|---|
| Module | Module 4 |
| Paper type | Critical appraisal of a single study (paper) |
| Length | About 1,040 words, 6 pages |
| Format | APA 7 student paper |
| School | Southern New Hampshire University |
| Program | MSN |
| Updated | September 2026 |
Free sample paper for NUR 550 Module 4
Critical Appraisal: How Strong Is the 1999 Evidence That Bundled Risk-Factor Care Prevents Delirium in Older Medical Patients?
[Student Name]
Southern New Hampshire University
NUR 550: Evidence-Based Practice and Scholarly Inquiry
Critical Appraisal
[Instructor Name]
[Date]
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
Critical Appraisal: How Strong Is the 1999 Evidence That Bundled Risk-Factor Care Prevents Delirium in Older Medical Patients?
The controlled trial published by Inouye et al. (1999) is the study most often cited for multicomponent delirium prevention, and much of what followed, including the Hospital Elder Life Program, grew from it. Frequent citation is not the same as strong evidence, so this appraisal examines the study's validity, results and applicability to the PICOT question developed for a 30-bed medical unit. It works through the three checks most appraisal frameworks share: whether the findings can be trusted, what they show and how precisely, and whether they transfer to this unit. The appraisal concludes that the study provides good but not definitive evidence, because prospective matching rather than randomization leaves room for confounding, and that its effect, about one case of delirium prevented for every 20 patients, is large enough to matter on a unit where one older patient in six becomes delirious.
Summary of the Study
Participants were 852 general medicine inpatients at a teaching hospital, all 70 or older. Patients on one intervention unit were matched with patients on two usual-care units using a prospective matching strategy. Standardized protocols targeted six risk factors: impaired cognition, poor sleep, lying in bed, trouble seeing, trouble hearing and too little fluid. Delirium, the primary outcome, was assessed daily until discharge (Inouye et al., 1999).
Are the Results Valid?
Design. The study was a controlled clinical trial but not a randomized one. Patients were enrolled on units assigned to the intervention or usual care, then matched on characteristics related to delirium risk. Matching controls for known confounders, but not for unknown ones, which is the central advantage of randomization. Unit-level differences in staff, culture or patient flow could also have influenced results.
Allocation and contamination. Delivering the intervention on a separate unit had a practical benefit: usual-care patients were unlikely to receive intervention components by accident, a common problem when both groups share the same nurses.
Measurement. Delirium was assessed daily with a standardized method, which reduces the chance that cases were missed or counted inconsistently. A daily outcome also captures episodes that brief or fluctuating delirium might otherwise hide.
Fidelity. Overall adherence to the intervention protocols was 87%, and the number of risk factors per patient fell significantly, suggesting the intervention was delivered largely as designed (Inouye et al., 1999). High adherence strengthens confidence that the observed effect came from the intervention itself.
What Are the Results?
The intervention group's delirium rate was 9.9%, against 15.0% under usual care; the matched odds ratio was 0.60, and its 95% interval ran from 0.39 to 0.92. Total days with delirium (105 vs. 161) and number of episodes (62 vs. 90) were also lower. The severity of delirium and recurrence rates did not differ significantly (Inouye et al., 1999).
Translated into absolute terms, the difference of 5.1 percentage points means that about 20 patients would need to receive the intervention to prevent one case of delirium (1 divided by 0.051). The confidence interval is wide, and its upper limit of 0.92 is close to no effect, so the true benefit could be considerably smaller than the point estimate. The absence of an effect on severity or recurrence suggests the program works by preventing delirium rather than by treating it once it begins.
Secondary Findings, Harms and Costs
Several secondary findings strengthen the case. Among patients who arrived with cognitive impairment, the intervention was associated with improvement in the degree of impairment, and across all patients it was associated with less use of sleep medicines, one of the modifiable contributors to delirium. Trends toward less immobility and fewer untreated vision and hearing problems pointed in the same direction (Inouye et al., 1999). The report describes no harms from the intervention, which is plausible given that its components are basic nursing and supportive care, although an appraiser should note that harms were not a primary focus.
The study did not report costs. Later work fills part of that gap: a replication in a community hospital reported lower costs over six months on a 40-bed unit (Rubin et al., 2006). For the unit, the more relevant cost is staff time, which the implementation plan will need to estimate directly.
Rating the Evidence
Using the Johns Hopkins hierarchy, a controlled trial without randomization is Level II evidence (Dang et al., 2022). The study's quality is good, grade B: the sample is adequate, the outcome is measured rigorously and adherence is high, but the lack of randomization and the single-site setting limit certainty. Later evidence has strengthened the conclusion. A Cochrane review of randomized trials judged, with moderate certainty, that multicomponent interventions probably reduce delirium incidence in hospitalized patients outside intensive care (Burton et al., 2021), which suggests the original finding was not an artifact of its design.
Will the Results Help on This Unit?
The patients match the unit's population well: adults 70 and older on a general medicine service. The six targeted risk factors are all common on the unit, and the unit's own audit found about one older patient in six with acute confusion, close to the 15% seen in the study's usual-care group. With a similar baseline risk, a similar absolute benefit is plausible.
Three differences temper that conclusion. The study was conducted at a teaching hospital in the late 1990s with a dedicated interdisciplinary team, and the intervention relied on trained staff and volunteers; the unit has no volunteer program and a leaner staffing model. Care has also changed, with shorter stays and more attention to sedative prescribing, which may already reduce baseline risk. Finally, the study measured outcomes with research staff, while the unit will rely on nurses screening with the 4AT, which may detect fewer cases.
Conclusion
The 1999 trial provides good, Level II evidence that a multicomponent intervention prevents delirium in older medical inpatients, with about one case prevented for every 20 patients treated. Its main weakness, prospective matching instead of randomization, is offset by later randomized evidence pointing the same way. The unit's patients and baseline risk resemble the study's, but its staffing does not, so the implementation plan will need to show how the six components can be delivered without volunteers.
References
Burton, J. K., Craig, L. E., Yong, S. Q., Siddiqi, N., Teale, E. A., Woodhouse, R., Barugh, A. J., Shepherd, A. M., Brunton, A., Freeman, S. C., Sutton, A. J., & Quinn, T. J. (2021). Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database of Systematic Reviews, 2021(7), Article CD013307. https://doi.org/10.1002/14651858.CD013307.pub2
Dang, D., Dearholt, S. L., Bissett, K., Ascenzi, J., & Whalen, M. (2022). Johns Hopkins evidence-based practice for nurses and healthcare professionals: Model and guidelines (4th ed.). Sigma Theta Tau International.
Inouye, S. K., Bogardus, S. T., Charpentier, P. A., Leo-Summers, L., Acampora, D., Holford, T. R., & Cooney, L. M. (1999). A multicomponent intervention to prevent delirium in hospitalized older patients. New England Journal of Medicine, 340(9), 669-676. https://doi.org/10.1056/NEJM199903043400901
Rubin, F. H., Williams, J. T., Lescisin, D. A., Mook, W. J., Hassan, S., & Inouye, S. K. (2006). Replicating the Hospital Elder Life Program in a community hospital and demonstrating effectiveness using quality improvement methodology. Journal of the American Geriatrics Society, 54(6), 969-974. https://doi.org/10.1111/j.1532-5415.2006.00744.x
What the NUR 550 Module 4 instructions ask for
The appraisal module in NUR 550 usually asks you to critically appraise one or more research studies related to your PICOT question. Prompts commonly ask you to summarize the study, evaluate its design and validity, interpret the results, rate the level and quality of evidence using a named hierarchy and decide how far the findings transfer to the place you work. Some sections supply an appraisal tool such as a CASP checklist or the Johns Hopkins appraisal forms. Plan on three to five pages in APA 7, sometimes with a completed appraisal form attached. Read the full article, not just the abstract, since details of allocation, measurement and adherence usually appear only in the methods section.
How this NUR 550 Module 4 critical appraisal example is built
In the sample, the 1999 controlled trial of multicomponent delirium prevention is appraised for a composite medical unit. The paper summarizes the study, then examines its validity through design, allocation, measurement and fidelity, noting that matching rather than randomization leaves room for unknown confounders. Results are reported precisely and translated into an absolute risk reduction of 5.1 percentage points and a number needed to treat of about 20, with a caution about the wide interval. The study is rated Level II, quality B, and set against a later Cochrane review. Applicability is judged against the unit's population, baseline risk and staffing. Three real sources support it, the trial itself, the Johns Hopkins model and the later Cochrane review.
Where the NUR 550 Module 4 rubric puts the points
Appraisal papers are generally graded on accurate summary of the study, depth of validity assessment, correct interpretation of results, appropriate use of an evidence hierarchy, analysis of applicability and writing. Validity assessment earns the most credit when it identifies specific threats, such as confounding in a non-randomized design, and explains their likely effect. Interpretation is strongest when relative measures are translated into absolute terms such as a number needed to treat, and when confidence intervals are read correctly. Applicability should compare the study's population and resources with your own setting, not simply state that the study is relevant. Mention harms and costs if the study reports them.
NUR 550 Module 4 help: the mistakes that cost points
Appraisals often lose points by summarizing the abstract without evaluating the methods, by labeling any trial as randomized, by reporting odds ratios without explaining them or by declaring the study applicable without comparison. Work through validity, results and applicability in order, name specific strengths and weaknesses, calculate absolute measures where the data allow, rate the evidence with the hierarchy your course uses and compare the study setting with yours. Relate the study to other evidence where you can. Quote numbers exactly as the article reports them. If your PICOT question points to a different study, we can prepare an appraisal of that study for your course.
Get NUR 550 Module 4 written to your instructions
Send the study you need to appraise, your PICOT question and the rubric or appraisal tool your course uses. A full appraisal with validity, results in absolute terms, an evidence rating and applicability to your setting is ready in 24 to 48 hours, and the first one is free. The paper above is an original model document written by our desk, not a submitted student paper and not an official Southern New Hampshire University document.
More NUR 550 papers and related MSN samples
- NUR 550 Module 1 Discussion: Framing Delirium on a Medical Unit as a Practice Problem
- NUR 550 Module 2 PICOT Question Paper: An Answerable Question About Delirium Prevention
- NUR 550 Module 3 Milestone One: A Documented, Repeatable Literature Search on Delirium Prevention
- NUR 550 Module 5 Evidence Synthesis: What the Evidence on Multicomponent Delirium Prevention Says Together
- NUR 550 Module 6 Milestone Two: Applying the i-PARIHS Framework to a Delirium Prevention Project
- NUR 550 Module 7 Implementation Plan: An Implementation Plan for a Delirium Prevention Bundle
- NUR 550 Module 8 Evaluation Plan: Evaluating a Delirium Prevention Bundle With RE-AIM
- NUR 550 Module 9 Final Project: A Complete Evidence Translation Proposal for Delirium Prevention
- NUR 550 Module 10 Journal: The Gap Between Knowing the Evidence and Changing Practice
- NUR 530 Module 1 Systems Thinking Paper: A Late Discharge as a System Problem
- NUR 508 Module 1 Role Definition Discussion
- NUR 540 Module 10 Journal: Thinking About Disease Across the Life Span
- NUR 520 Module 5 Statistical Inference Paper: Confidence Intervals Around County Estimates
NUR 550 Module 4 questions, answered
Where can I find a free NUR 550 Module 4 Critical Appraisal sample?
The complete appraisal on this page is free to read: the 1999 multicomponent delirium prevention trial judged for validity, results, number needed to treat, evidence level and fit with a composite medical unit, with three real sources.
What questions does a critical appraisal answer?
Whether the results are valid, what the results are and how precise they are, and whether they will help in your own setting.
How do I calculate a number needed to treat?
Divide 1 by the absolute risk reduction. For delirium rates of 15.0% and 9.9%, the reduction is 0.051, so about 20 patients must be treated to prevent one case.
Is a matched controlled trial as strong as a randomized trial?
No. Matching controls for known confounders but not unknown ones, so a non-randomized controlled trial is usually rated a level below a randomized trial.
How do I judge whether a study applies to my unit?
Compare the population, baseline risk, resources and outcome measurement in the study with those in your setting, and explain how differences might change the effect.